AITL	Angioimmunoblastic T-cell lymphoma
PTCL-NOS	Peripheral T-cell lymphoma, not otherwise specified
RHOA	Ras homolog family member A
NGS	Next-generation sequencing
FFPE	Formalin-fixed, paraffin-embedded
PCR	Polymerase chain reaction
DDR	DNA damage response
BV	Brentuximab vedotin
BV-CHP	Brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone
ASCT	Autologous stem cell transplantation
TFH	T-follicular helper (cell)
LDH	Lactate dehydrogenase
ECOG PS	Eastern Cooperative Oncology Group performance status
ALCL	Anaplastic large cell lymphoma
EBER	EBV-encoded RNA in situ hybridization
IPI	International Prognostic Index
HR	Hazard ratio
CI	Confidence interval
PFS	Progression-free survival
OS	Overall survival
KMT2A-r	KMT2A rearrangement
CHP	Cyclophosphamide, doxorubicin, and prednisone
CR	Complete remission